ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: cardiovascular disease

The ACR/ARHP Annual Meeting: Rheumatoid Arthritis Raises Mortality Risk in Women

Kathy Holliman  |  January 1, 2015

Data from Nurses’ Health Study, other clinical trials point to higher risk of respiratory, cardiovascular disease death in women with RA

Filed under:ConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:2014 ACR/ARHP Annual MeetingcardiovascularHollimanmortalityNurses' Health StudyResearchrespiratoryRheumatoid arthritisWomen

What Diet to Recommend to Patients with Rheumatoid Arthritis?

Vanessa Caceres  |  November 1, 2013

With no clear-cut, evidence-based dietary guidelines for RA, rheumatologists should advocate for a balanced diet to help patients reduce their risk of obesity, cardiovascular disease, and osteoporosis

Filed under:ConditionsRheumatoid Arthritis Tagged with:Dietevidence-based guidelinesnutritionRheumatoid arthritis

ACR/ARHP Annual Meeting 2012: How to Manage Gout Effectively in the Context of Comorbid Conditions

Mary Beth Nierengarten  |  January 1, 2013

Comorbid conditions such as chronic kidney disease and cardiovascular disease can complicate gout management, but effective treatment and preventive strategies are available

Filed under:ConditionsGout and Crystalline ArthritisMeeting Reports Tagged with:ACR/ARHP Annual MeetingGouthyperuricemiaTreatment

As Population Ages, Rheumatologists Prepare to Treat Elderly Patients with More Comorbidities

Vanessa Caceres  |  November 1, 2012

Cardiovascular disease, diabetes are among the conditions that add another layer of complexity in treating older rheumatology patients

Filed under:Clinical Criteria/GuidelinesConditionsGout and Crystalline ArthritisOsteoarthritis and Bone DisordersRheumatoid Arthritis Tagged with:anti-inflammatorydruggeriatricGoutHYDROXYCHLOROQUINEOsteoarthritispatient carepatient communicationPatientsPractice ManagementRheumatoid arthritisTreatmentvaccine

Aggressive Urate Lowering Needed for Gout

Kathy Holliman  |  July 1, 2010

Patients with gout at increased risk for cardiovascular disease and adverse event

Filed under:Clinical Criteria/GuidelinesConditionsGout and Crystalline Arthritis Tagged with:Cardiovascular diseaseGoutPaintherapyTreatmenturate-lowering therapies

The Great Pediatric Debate—Corticosteroids in SLE: Slay or Stay?

Michael Cammarata, MD, RhMSUS  |  December 10, 2025

Long-term use of corticosteroids is associated with numerous adverse effects, particularly in children, but guidance is lacking on how to manage low-dose prednisone in clinically quiescent disease. In The Great Debate at ACR Convergence 2025—Corticosteroids in Pediatric SLE: Slay or Stay, two pediatric lupus experts took to the stage to explore this important topic.

Filed under:ACR ConvergenceConditionsDrug UpdatesMeeting ReportsPediatric Conditions Tagged with:ACR Convergence 2025GlucocorticoidsSteroidstapering

Insights into SLE & Lupus Nephritis From the 2025 Review Course

Jason Liebowitz, MD  |  December 7, 2025

Review expert strategies & clinical pearls for managing SLE & lupus nephritis. Get therapeutic updates from the ACR’s 2025 Review Course.

Filed under:ACR ConvergenceConditionsMeeting ReportsPediatric ConditionsSystemic Lupus Erythematosus Tagged with:belimumabDr. Stacy ArdoinLupus Low Disease-Activity State (LLDAS)Lupus nephritis supplementneuropsychiatric lupusobinutuzumabPediatric RheumatologyTreat-to-Target

Complications: Renal Arteriosclerosis in Patients with Lupus Nephritis

Mary Beth Nierengarten  |  November 21, 2025

Renal arteriosclerosis is common in patients with lupus nephritis and occurs two decades earlier than it does in people without the condition, say investigators in a study that examined the prevalence of renal arteriosclerosis in patients with lupus nephritis compared with healthy controls.1 The finding suggests that renal arteriosclerosis could be used as a biomarker…

Filed under:ConditionsResearch RheumSystemic Lupus Erythematosus Tagged with:Lupus nephritisRenal arteriosclerosis

Exploring Cognitive Dysfunction in Rheumatology

Ruth Jessen Hickman, MD  |  November 17, 2025

At this ACR Convergence Session, experts discussed brain fog experienced by many patients with rheumatic diseases & ways rheumatologists can help patients feel better supported.

Filed under:ACR ConvergenceMeeting ReportsRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAcognitive dysfunctionFibromyalgiaRheumatoid arthritisScleroderma

ACR Releases New Guideline for Management of SLE at ACR 2025

Mithu Maheswaranathan, MD  |  November 14, 2025

Updating the last iteration in 1999, the new ACR Guideline for Management of SLE was unveiled at ACR Convergence 2025, providing rheumatologists an organ-based approach for therapeutic options for specific lupus manifestations.

Filed under:ACR ConvergenceClinical Criteria/GuidelinesConditionsGuidanceMeeting ReportsSystemic Lupus Erythematosus Tagged with:ACR Convergence 2025BiologicsClinical Practice GuidelinesLupussystemic lupus erythematosus (SLE)

  • « Previous Page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • …
  • 66
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2026 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences